Frequently asked.

AI UX is the design discipline that shapes how people interact with non-deterministic systems (agents, copilots, predictive interfaces) where the output isn't fixed and trust is the core design material. Traditional UX optimizes a known path. AI UX designs for ambiguity, correction, and judgment, which means the work lives in workflow logic, content readiness, and trust signals. Not interface novelty.

AI adoption is not a technology problem. It's an experience architecture problem. The model works, the integration works, the platform works. But if the workflow is unclear, the content is messy, the decision logic is hidden, or users don't trust the output, adoption stalls. That's design work, not engineering work.

You treat compliance as a design constraint, not an afterthought. That means mapping every AI touchpoint to its regulatory surface (FDA, HIPAA, MLR, SOC 2), structuring content for auditability, and building human-in-the-loop checkpoints where model confidence drops. I've done this across 70+ therapeutic brands and major enterprise systems.

Build the HCP and DTC review rules in from the start, instead of retrofitting them after a review goes wrong. Early concept reviews show what reviewers will approve, from a new phrasing to a new interactive feature, before the work is built. I bring regulatory partners and medical strategists in as collaborators, not gatekeepers. For established brands, I use modular, pre-approved components and shared governance. For first-in-disease launches, where there's nothing to reuse, I work with the team to build visual examples and a pharma-first narrative, so the review path is set up for the best chance of approval. On a multi-brand sales tools program, pre-approved components and a direction vetted in concept review helped save time to market and team hours across brands.

I'm most useful when the problem or opportunity still needs definition, when senior UX judgment is needed across disciplines, or when a team needs experienced leadership without adding another full-time role. I can work directly with a brand, embed inside an agency engagement, or work alongside an internal product or technology team. The goal is to strengthen the team already there, not create another layer of process.

Yes. I work as a fractional or freelance senior UX and design leader for pharma, healthcare, and other regulated teams: directly with brands, embedded inside agency engagements, or alongside internal product and technology teams. The work has included design governance across 70+ therapeutic brands, a patient navigation platform, and multi-brand sales tools. Engagements can be project-based, ongoing, or embedded, and I work remote-first, onsite when being in the room adds value. See the three ways to bring me in.

3 principles, 6 flexible actions, and clear momentum. The principles stay constant: listen first, make it visible, prove it worked. The six actions (Inputs, Questions, Findings, Activation, Measurement, and Summary) are used where the work needs them: in sequence, repeated, combined, or revisited when new information changes the problem. The outcome is clear momentum: the team knows what it's trying to accomplish, the work is visible enough to improve, and decisions move forward on evidence. The Process is the spine of the case studies, the book, the Clarity Cards, and the workshops on this site.

Pharmaceutical and healthcare (oncology, cardiovascular, vaccines, multiple sclerosis, hemophilia, immunology, rare disease, HIV/AIDS, women's health), financial services and enterprise data, and consumer technology, with deep specialization in AI integration for regulated environments. The throughline is high-stakes, compliance-bound work where bad UX has real legal, clinical, or financial consequences.

$270M+ in tracked revenue impact across pharma, fintech, and enterprise engagements. Specific wins include a D&AD Pencil-recognized equity-focused cancer care platform, multi-brand digital transformation across 70+ therapeutic brands ($3.5M+ documented investment), and $1.5M+ in annual ROI from an enterprise financial services CRM transformation. Outcomes vary by engagement scope. The case studies on this site walk through specifics.

Every engagement starts with an initial conversation, usually 30 minutes. We talk through what's stuck and what success looks like. No pitch. If there's not a fit, I'll tell you and try to point you to possible solutions or partners. If there is, we move into a longer scoping conversation with the relevant stakeholders to map scope, timing, and constraints. Then I write the Statement of Work. Most engagements move from first call to signed SOW in 2–3 weeks.

Both. I work directly with brands and embed as senior UX and experience leadership inside agency engagements. I'm especially useful when the work is regulated, enterprise-scale, AI-heavy, or still needs clearer definition. I work inside the team's existing process and tools, with the level of involvement shaped around the work.

Yes. I work inside your tools, training, and process, not beside them, whether that's an enterprise playbook or a start-up still writing its own. Where the process slows the work, I help refine it. I work alongside product, creative, strategy, account, regulatory, research, and development teams, and I've directed vendor teams onshore and offshore.

Both. Most of my client work has been enterprise and regulated: pharma, healthcare, and financial services. I also design, build, and ship my own products, like CourtVisual and AI Patient Support, so I know the start-up side from the inside: small teams, fast decisions, and getting something usable in front of people.

Either, and it's built to flex. Most engagements start with a single defined piece of work and grow into an ongoing relationship as needs change. You can move between embedded leadership, advisory, and on-call support without renegotiating from scratch. The intensity flexes with what you need; the partnership stays in place. An initial conversation is the right starting point if you're trying to figure out which structure makes sense for your team.

Most work is remote, and virtual delivery is included in every engagement. I travel for onsite work when being in the room is the right call. Workshops, executive presentations, and stakeholder alignment sessions are often better in person, and I bill travel at cost.